Indivior PLC $INDV Stock Acquired by Profund Advisors LLC

Profund Advisors LLC increased its position in Indivior PLC (NASDAQ:INDV) by 268.8% in the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 49,650 shares of the company’s stock after purchasing an additional 36,188 shares during the period. Profund Advisors LLC’s holdings in Indivior were worth $1,780,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently bought and sold shares of INDV. Vise Technologies Inc. increased its holdings in shares of Indivior by 33.0% in the 3rd quarter. Vise Technologies Inc. now owns 9,298 shares of the company’s stock valued at $333,000 after acquiring an additional 2,306 shares during the last quarter. State of Wyoming raised its stake in Indivior by 75.5% during the third quarter. State of Wyoming now owns 6,505 shares of the company’s stock worth $233,000 after acquiring an additional 2,799 shares during the period. China Universal Asset Management Co. Ltd. lifted its holdings in Indivior by 11.0% in the third quarter. China Universal Asset Management Co. Ltd. now owns 21,533 shares of the company’s stock worth $788,000 after acquiring an additional 2,129 shares during the last quarter. Sterling Capital Management LLC lifted its holdings in Indivior by 482.1% in the third quarter. Sterling Capital Management LLC now owns 3,772 shares of the company’s stock worth $135,000 after acquiring an additional 3,124 shares during the last quarter. Finally, Nisa Investment Advisors LLC boosted its stake in Indivior by 831.9% in the third quarter. Nisa Investment Advisors LLC now owns 20,642 shares of the company’s stock valued at $740,000 after acquiring an additional 18,427 shares during the period. 60.33% of the stock is owned by institutional investors.

Insider Activity at Indivior

In other news, CAO Woodrow D. Anderson bought 1,500 shares of the firm’s stock in a transaction that occurred on Thursday, August 27th. The stock was acquired at an average price of $35.69 per share, with a total value of $53,535.00. Following the completion of the purchase, the chief accounting officer directly owned 27,638 shares of the company’s stock, valued at $986,400.22. This represents a 5.74% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available through the SEC website. Corporate insiders own 0.74% of the company’s stock.

Indivior Stock Performance

NASDAQ:INDV opened at $36.28 on Tuesday. Indivior PLC has a 1 year low of $27.68 and a 1 year high of $42.81. The stock has a market cap of $4.28 billion, a price-to-earnings ratio of 9.53 and a beta of 0.87. The business has a fifty day moving average of $35.18 and a 200-day moving average of $35.63.

Indivior (NASDAQ:INDV) last issued its quarterly earnings data on Thursday, October 29th. The company reported $1.32 earnings per share for the quarter, beating analysts’ consensus estimates of $1.06 by $0.26. The business had revenue of $356.00 million for the quarter, compared to analysts’ expectations of $329.35 million. Indivior had a net margin of 26.65% and a negative return on equity of 283.11%. On average, equities research analysts predict that Indivior PLC will post 3.66 EPS for the current year.

Indivior Dividend Announcement

The company also recently declared a special dividend, which will be paid on Friday, November 6th. Stockholders of record on Friday, October 30th will be given a dividend of $8.13 per share.

Analysts Set New Price Targets

INDV has been the subject of a number of recent research reports. Wall Street Zen downgraded Indivior from a “strong-buy” rating to a “buy” rating in a research note on Saturday. Barclays lifted their price objective on shares of Indivior from $43.00 to $45.00 and gave the company an “overweight” rating in a research report on Wednesday, October 28th. Zacks Research raised shares of Indivior from a “hold” rating to a “strong-buy” rating in a research note on Friday, October 2nd. Weiss Ratings lowered shares of Indivior from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Thursday, September 24th. Finally, Craig Hallum reaffirmed a “buy” rating and set a $53.00 price target on shares of Indivior in a report on Tuesday, August 4th. One equities research analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and one has issued a Hold rating to the company. Based on data from MarketBeat, Indivior has an average rating of “Buy” and an average price target of $46.40.

Indivior Company Profile

Indivior PLC (NASDAQ:INDV) is a global pharmaceutical company focused on developing and commercializing medicines for substance use disorders and serious mental health conditions. Its portfolio is centered on treatments for opioid use disorder, opioid overdose, and related medical needs.

The company’s principal products include Sublocade, an extended-release buprenorphine injection for opioid use disorder; Suboxone, a buprenorphine and naloxone treatment available in film and other formulations; and Opvee, a nalmefene nasal spray intended for the emergency treatment of known or suspected opioid overdose.